Mitotic count in breast cancer: the influence of training on performance

Pathology Research and Practice

Volumn 192, Issue 11, 1996, Pages 1095-1099

  Kuopio, T ^a   Collan, Y ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Breast cancer; Cell proliferation; Mitotic index

Indexed keywords

ARTICLE; BREAST CANCER; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; MITOSIS INDEX; MITOSIS RATE; OBSERVER VARIATION; STAFF TRAINING;

EID: 0030512734     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80025-2     Document Type: Article

References (16)

1. Aaltomaa S. Lipponen P, Eskelinen M, Kosma V-M, Marin S, Alhava E, Syrjäne K (1992) Mitotic indexes as prognostic predictors in female breast cancer. J Cancer Res Clin Oncol 118: 75-81
2. Baak JPA, Dop v.H, Kurver PHJ, Hermans JO (1985) The value of morphometry to classic prognosticators in breast cancer. Cancer 56: 374-382
3. Collan Y, Kumpusalo L, Pesonen E, Eskelinen M, Pajarinen P, Kettunen K: Prediction of prognosis of breast cancer (1988) Multivariate analysis of mitotic index, lymph node status, and tumor size. Abstracts, XXI Nordic Congress on Pathology and Cytology, Oulu, June 20-23,. Acta Universitatis Ouluensis, Series D Medica 174: 8
4. Collan Y, Haapasalo H (1991) The value of mitotic counting in the assessment of prognosis and proliferation in human tumours. J Pathol 163: 361-364
5. Collan Y (1992) Mitotic counts for grading and prognostication of cancer. Interpretation of volume corrected mitotic index. Acta Stereologica 11: Suppl. 1: 717-722
6. Collan Y, Kuopio T, Baak JPA, et al. (1996) Standardized mitotic counts in breast cancer. Evaluation of the method. Pathol Res Pract 192: 931-941
7. Elston CW, Ellis I (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410
8. Haapasalo H, Pesonen E, Collan Y (1989) Volume corrected mitotic index (M/V index). The standard of mitotic activity in neoplasms. Path Res Pract 185: 551-554
9. Kallioniemi OP, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T (1987) Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol 23: 277-282
10. Kujari HP, Collan YUI, Atkin NB (1994) Use of mitotic counts for the prognosis and grading of breast cancer. Method evaluation study. Path Res Pract 190: 593-599
11. Laroye GJ, Minkin S (1991) The impact of mitotic index on predicting outcome in breast carcinoma: A comparison of different counting methods in patients with different lymph node status. Mod Pathol 4: 456-460
12. Montironi R, Collan Y, Scarpelli M, Sisti S, Barbatelli G, Carnevali A, Pisani E, Mariuzzi GM (1988) Reproducibility of mitotic counts and identification of mitotic figures in malignant glial tumors. Appl Pathol 6: 258-265
13. Quinn CM, Wright NA (1990) The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 160: 93-102
14. Simpson JF, Page DL (1994) Status of breast cancer prognostication based on histopathologic data. Am J Clin Pathol 102 (Suppl):S3-S8
15. van Diest PJ, Baak JPA (1991) The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients. Hum Pathol 22: 326-330
16. van Diest PJ, Baak JPA, Matze-Cok P, et al. (1992) Hum Pathol 23: 603-607